📰 Development Solutions News
Page 24 - Development Solutions News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Development Solutions. Real-time updates on events, politics, business and more.
November 10, 2023
Vestmark Advisory Solutions Inc. lifted its stake in IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 10.9% during the second quarter, HoldingsChannel reports. The firm owned 1,800 shares of the medical research company’s stock after purchasing an additional 177 shares during the period. Vestmark Advisory Solutions Inc.’s holdings in IQVIA were worth $405,000 at the […]
November 10, 2023
Machina Capital S.A.S. purchased a new position in shares of IQVIA Holdings Inc. (NYSE:IQV – Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 1,139 shares of the medical research company’s stock, valued at approximately $256,000. Other institutional investors […]
November 6, 2023
Lincoln National Corp increased its stake in shares of IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 2.1% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,356 shares of the medical research company’s stock after purchasing an additional 89 […]
November 5, 2023
Envestnet Asset Management Inc. grew its stake in shares of IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 3.8% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 372,832 shares of the medical research company’s stock after buying an additional 13,504 shares during the period. […]
November 4, 2023
IQVIA Holdings Inc. (NYSE:IQV – Get Free Report) shares saw unusually-high trading volume on Thursday . Approximately 2,658,519 shares changed hands during mid-day trading, an increase of 151% from the previous session’s volume of 1,058,978 shares.The stock last traded at $185.31 and had previously closed at $180.01. Analyst Upgrades and Downgrades IQV has been the […]
November 4, 2023
IQVIA (NYSE:IQV – Free Report) had its target price lowered by Guggenheim from $253.00 to $220.00 in a research note released on Friday, Benzinga reports. The brokerage currently has a buy rating on the medical research company’s stock. Several other equities research analysts have also commented on IQV. Mizuho decreased their price target on IQVIA […]
November 3, 2023
Clegg Construction has broken ground on a new £35m student accommodation scheme in Leeds.
November 3, 2023
IQVIA (NYSE:IQV – Get Free Report) had its target price reduced by equities research analysts at Morgan Stanley from $240.00 to $225.00 in a research note issued to investors on Friday, Benzinga reports. The firm presently has an “overweight” rating on the medical research company’s stock. Morgan Stanley’s target price indicates a potential upside of […]
November 3, 2023
IQVIA (NYSE:IQV – Get Free Report) had its price target dropped by stock analysts at Truist Financial from $260.00 to $240.00 in a research report issued on Friday, Benzinga reports. The brokerage presently has a “buy” rating on the medical research company’s stock. Truist Financial’s price objective points to a potential upside of 25.98% from […]
November 3, 2023
IQVIA (NYSE:IQV – Get Free Report) had its price target lowered by Truist Financial from $260.00 to $240.00 in a report issued on Friday, Benzinga reports. The brokerage presently has a “buy” rating on the medical research company’s stock. Truist Financial’s price objective points to a potential upside of 25.98% from the stock’s current price. […]